Dayong Lou

447 total citations · 1 hit paper
13 papers, 318 citations indexed

About

Dayong Lou is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Dayong Lou has authored 13 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Dayong Lou's work include Medicinal plant effects and applications (3 papers), Plant-derived Lignans Synthesis and Bioactivity (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Dayong Lou is often cited by papers focused on Medicinal plant effects and applications (3 papers), Plant-derived Lignans Synthesis and Bioactivity (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Dayong Lou collaborates with scholars based in China and Germany. Dayong Lou's co-authors include Liqin Zhou, Qinjie Weng, Bo Yang, Jincheng Wang, Qiaojun He, Jiajia Wang, Chunyan Fang, Jibo Han, Liqin Jiang and Jianjiang Xu and has published in prestigious journals such as Food Research International, Phytomedicine and Acta Pharmacologica Sinica.

In The Last Decade

Dayong Lou

13 papers receiving 313 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural products: potential treatments for cisplatin-induced nephrotoxicity

2021 258 citations Chunyan Fang, Dayong Lou et al. Acta Pharmacologica Sinica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dayong Lou China	5	166	78	53	41	35	13	318
Liqin Zhou China	8	161 1.0×	146 1.9×	54 1.0×	42 1.0×	44 1.3×	16	401
Ademar Dantas da Cunha Júnior Brazil	7	190 1.1×	60 0.8×	78 1.5×	52 1.3×	59 1.7×	8	331
Baiye Jin China	11	198 1.2×	153 2.0×	36 0.7×	47 1.1×	63 1.8×	34	515
Hongzhou Meng China	11	172 1.0×	130 1.7×	27 0.5×	72 1.8×	46 1.3×	18	535
Blessy George United States	9	90 0.5×	73 0.9×	81 1.5×	46 1.1×	56 1.6×	20	353
Abdelghany H. Abdelghany Egypt	11	98 0.6×	52 0.7×	11 0.2×	16 0.4×	32 0.9×	17	376
Xiaowen Bao China	10	37 0.2×	166 2.1×	18 0.3×	26 0.6×	24 0.7×	12	364
Zahra Jalali Iran	7	49 0.3×	89 1.1×	21 0.4×	21 0.5×	32 0.9×	24	281
Ashraf Youssef Nasr Egypt	11	116 0.7×	37 0.5×	9 0.2×	19 0.5×	13 0.4×	22	328
Amal M. H. Ghanim Egypt	10	42 0.3×	122 1.6×	16 0.3×	18 0.4×	30 0.9×	12	316

Countries citing papers authored by Dayong Lou

Since Specialization

Citations

This map shows the geographic impact of Dayong Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayong Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayong Lou more than expected).

Fields of papers citing papers by Dayong Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayong Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayong Lou. The network helps show where Dayong Lou may publish in the future.

Co-authorship network of co-authors of Dayong Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Dayong Lou. A scholar is included among the top collaborators of Dayong Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayong Lou. Dayong Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Chen, Yuanyuan, Yan Chen, Zhen Hong, & Dayong Lou. (2025). Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials. The Egyptian Journal of Neurosurgery : the official publication of the Egyptian Society of Neurological Surgeons/Egyptian journal of neurosurgery. 40(1). 1 indexed citations

Qiu, Jiang, Na Yang, Shuo Huang, et al.. (2025). Vine tea (Ampelopsis grossedentata) ameliorates chronic alcohol-induced hepatic steatosis, oxidative stress, and inflammation via YTHDF2/PGC-1α/SIRT3 axis. Food Research International. 209. 116321–116321. 1 indexed citations

Ma, Qing, Shuo Huang, Fang‐Ming Chen, et al.. (2025). Dihydromyricetin regulates the miR-155-5p/SIRT1/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury. Phytomedicine. 139. 156522–156522. 4 indexed citations

Lou, Dayong, et al.. (2024). Dihydromyricetin reverses capecitabine‐induced peripheral myelin dysfunction through modulation of oxidative stress. Clinical and Experimental Pharmacology and Physiology. 51(3). e13833–e13833. 1 indexed citations

Hong, Chunlan, Shuo Huang, Jiang Qiu, et al.. (2024). An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway. Phytomedicine. 132. 155658–155658. 13 indexed citations

Zhou, Liqin, et al.. (2024). Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy. Revista Brasileira de Farmacognosia. 34(4). 880–881. 1 indexed citations

Kong, Yu, et al.. (2024). Navigating Therapeutic Opportunities and Challenges with Micro/Nanomotors in Translational Medicine: A Review. ACS Applied Nano Materials. 7(20). 23321–23336. 5 indexed citations

Zhou, Liqin, et al.. (2023). Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy. Revista Brasileira de Farmacognosia. 33(5). 945–953. 2 indexed citations

Cai, Yajun, et al.. (2022). Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells. Journal of Gastrointestinal Oncology. 13(3). 1255–1265. 3 indexed citations

10.

Fang, Chunyan, Dayong Lou, Liqin Zhou, et al.. (2021). Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacologica Sinica. 42(12). 1951–1969. 258 indexed citations breakdown →

11.

Han, Jibo, Liqin Zhou, Qi Yu, et al.. (2018). Inhibition of Epidermal Growth Factor Receptor (EGFR) Reduces Lipopolysaccharide (LPS)-Induced Activation and Inflammatory Cytokines in Hepatic Stellate Cells In Vitro. Medical Science Monitor. 24. 5533–5541. 12 indexed citations

12.

Lou, Dayong, et al.. (2018). Fibroblast growth factor receptor 1 antagonism attenuates lipopolysaccharide‑induced activation of hepatic stellate cells via suppressing inflammation. Experimental and Therapeutic Medicine. 16(4). 2909–2916. 14 indexed citations

13.

Han, Jibo, Liqin Jiang, Jianjiang Xu, et al.. (2018). Schisandrin B attenuates lipopolysaccharide-induced activation of hepatic stellate cells through Nrf-2-activating anti-oxidative activity.. PubMed. 11(10). 4917–4925. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact